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Introduction
Establishedrenalfailure(ERF)inchildrenandyoungadults
is considered a rare disease. Single country data may be un-
derpowered to show any differences or effects of treatment
and therefore cooperation between countries is essential
to improve the outcome of children with ERF. Until 2007
data collection on children and young adults on renal re-
placement therapy (RRT) in Europe was limited to that
of the European Renal Association–European Dialysis and
Transplant(ERA–EDTA)Registry.WithintheERA–EDTA
Registry data are collected from national and regional re-
nal registries. As these do not always include paediatric
patients, data on children have only been available from a
limited part of Europe. The first publication on paediatric
patients by the Amsterdam-based ERA–EDTA Registry in-
cluded data on 3184 patients (aged 0–19 years) from 12
registries in 11 countries, covering a total general popula-
tion of 80.3 million, who started RRT between 1980 and
2000 [1]. Information was presented on incidence, preva-
lence, primary renal disease, age at onset of RRT, type of
treatment and survival. The data demonstrated an almost
3-fold increase in the prevalence of ERF over 20 years,
from 22.9 per million age related population (pmarp) in
1980 to 62.1 pmarp in 2000. The incidence rose from 7.1
pmarp in the 1980–84 cohorts to 9.9 pmarp in the 1985–
89 cohorts but then remained stable. In the early cohort
haemodialysis was the most common form of first treat-
ment modality, but by 1995–2000 peritoneal dialysis and
pre-emptive transplant were increasingly used. Over the 20
years studied the relative risk of death for patients starting
dialysis or following their first transplant reduced by 36%
and 42%, respectively.
A paper on the characteristics and survival of young
adults who started RRT during childhood has recently been
published [2], and a further study on the effect of timing of
transplantation is in progress. In addition, an international
study comparing survival between children on haemodial-
ysis and peritoneal dialysis is running in collaboration with
other large registries including the USRDS and ANZDATA
[3].
Since2004preparationshavebeenmadeforamorecom-
prehensive registry specifically focusing on children, the
EuropeanSocietyforPaediatricNephrology(ESPN)/ERA–
EDTA Registry. It was decided that the data collection on
childrenshouldbeexpandednotonlytoincludemorecoun-
triesbutalsotocollectmuchmoredetaileddataondifferent
aspectsofERFmanagement.Initially,establishedregistries
fromthelargercountrieswerecomparedtoseeifacommon
database could be developed. A paediatric sub-committee
of the ERA–EDTA Registry committee was set up to fur-
ther develop the paediatric aspects of the Registry. This led
to a comparison of UK and Italian data that was presented
at the ERA–EDTA meeting in Lisbon in ‘Auditing and Ad-
vancing Paediatric RRT’. This comparison demonstrated
that these two countries not only had very similar popula-
tions of children with ERF, but there was also evidence of
differences in management, for example of haemodialysis
access and time to transplantation. In 2005, with the inclu-
sion of patients from the UK, Italy and Turkey, the total
number of incident patients under the age of 15 reported to
the ERA–EDTA Registry increased from 2009 to 4280 and
details were reported at the ESPN meeting in Istanbul 2005
in ‘The new paediatric EDTA database’.
At the same time the ERA–EDTA Registry set out to
develop the QUEST (QUality European STudies) initia-
tive [4]. The aim of this initiative is to identify comparable
indicators to assess the quality of RRT care among Euro-
pean countries, with the aim of improving outcome across
Europe. One of the ways of reaching that objective is to
develop and standardize clinical performance indicators to
be used for (inter)national benchmarking. Together with
national renal registries and societies the ERA–EDTA Reg-
istry applied to the European Union for a grant, under the
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Fig. 1. Countries contributing data to the ESPN/ERA–EDTA Registry.
name of NephroQUEST, which was subsequently awarded
in 2007. The project was officially launched at a meeting in
Amsterdam in November 2007 [5]. It is hoped that this
project will support the development of the infrastructure
requiredfordatacollectionincountrieswithoutthisfacility
that will then be of benefit to both children and adults with
renal failure. The NephroQUEST grant has also provided
co-funding for the employment of a part-time dedicated
epidemiologist, for the paediatric registry, for 3 years. Con-
tributions to the funding for this post have also been pro-
vided by the ERA–EDTA and the ESPN for this period and
action is now required to secure long-term funding.
The launch of the ESPN/ERA-EDTA Registry
In 2007 the combined ESPN/ERA–EDTA Registry was of-
ficiallylaunched.Anepidemiologistwasappointedtowork
with the AMC-based ERA–EDTA Registry and the two
ESPN representatives with the ERA–EDTA Registry com-
mittee, in order to develop the separate paediatric aspects
of the Registry. Forty European countries were contacted
via the presidents of national societies or known registry
leads and 35 responded favourably to being interested in
participating in the future registry. Since then 33 paediatric
registries (29 countries) have contributed data (Figure 1).
As of September 2008 the Registry had collected data from
countries covering a total general population of ∼400 mil-
lion individuals.
To facilitate data collection, particularly for those
countries without established registries, a new paediatric
database has been developed which has been distributed
to all European countries. Individual patient data will be
collected on all patients starting RRT. The database has
been sent to the national representatives who are respon-
sible for the data collection. They can decide to send data
from their national registry to the ESPN/ERA–EDTA Reg-
istry directly, import the data from their registry into the
ESPN/ERA–EDTA database or ask the different centres to
providetheindividualpatientdatadirectlyintothedatabase.
Although a significant amount of data will be collected on
all patients, the database also allows identification of spe-
cific cohorts that might be the subject of more in depth
analysis as part of a separate research project.Nephrol Dial Transplant (2009) 24: Editorial Comments 2617
The data collection is structured into the ERA–EDTA
core dataset (essential) including date of birth, gender,
cause of renal disease, date of first RRT, treatment modal-
ity, changes of therapy, death and its cause and transfer to
other countries and two extended datasets (based on
NephroQUEST datasets adapted for children); the first ex-
tension ‘A’ including high priority data collection and the
second extension ‘B’ with medium priority data collection.
These extended datasets will enable the registry to collect
more detailed information from cohorts of patients in order
to study more specific areas.
Currently24/29ofthecountriesincludedare100%com-
plete with respect to patients for their coverage area and
25/29 cover both dialysis and transplant patients. The level
of detail of data collection differs by country, some coun-
tries collecting the minimum dataset of 9 variables and
others of >50 variables. However, it is hoped that the new
database will improve the level of detail and the standard-
ization of data collection for all countries.
In the future, if quality is sufficient, and the coverage
could be guaranteed, it is hoped that the data collection will
expand to include those with pre-end-stage renal failure.
Future plans for the ESPN/ERA-EDTA Registry
Whereas different projects and related papers on paediatric
ESRF are in progress within the ERA–EDTA Registry, the
more extensive data collection within the Registry will en-
able more specific research projects to be developed.
The Registry provides the opportunity to study signifi-
cant numbers of children with rare causes of renal failure.
For example, haemolytic uraemic syndrome (HUS), partic-
ularly atypical HUS, is a rare cause of renal failure overall
(accounting for 2.9% of patients with ERF [6]). Combining
experience from the whole of Europe will allow improved
statistical power and therefore more meaningful analysis of
thedata.ThisRegistrycanalsobeusedasasamplingframe
to identify cohorts of children in whom even more detailed
research could be undertaken. Areas that have already been
identified for detailed study include growth, nutrition, car-
diovascular morbidity and risk factors, RRT in infants and
specific conditions such as management of focal segmental
glomerulosclerosis or HUS in the post-transplant period.
Two further issues are important in studying paediatric
RRT. Firstly, as a large proportion of the children have a
transplant, a strong collaboration between transplant and
dialysis registries is essential. It is recommended that the
two should be merged into one RRT registry to ensure that
theentiretherapyhistoryfromallchildrenisavailable.Sec-
ondly, in paediatrics the improvement in care requires the
knowledge of not only the short-term outcome but also of
the long-term outcome of the patients who have received
RRT in childhood, in terms of survival, comorbidity and
treatment-related complications. For this reason it is essen-
tial that paediatric registries develop seamless collabora-
tion, in data collection and reporting, with registries only
collectingdataonadultpatients.Therefore,allnationalreg-
istries, the paediatric as well as those collecting adult data,
are encouraged to develop these links in the near future.
Physicians, researchers and others interested in research
in paediatric nephrology are highly encouraged to suggest
research questions, initiate projects within the ESPN or to
visit the ESPN/ERA-EDTA Registry for an internship in
paediatric RRT research.
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